Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$1.28B |
| 2 |
Walmart Inc
WMT
|
+$595M |
| 3 |
TSMC
TSM
|
+$567M |
| 4 |
Boeing
BA
|
+$565M |
| 5 |
Edwards Lifesciences
EW
|
+$526M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.78B |
| 2 |
Mercado Libre
MELI
|
+$1.44B |
| 3 |
ASML
ASML
|
+$1.05B |
| 4 |
Broadcom
AVGO
|
+$878M |
| 5 |
MongoDB
MDB
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Consumer Discretionary | 16.21% |
| 3 | Communication Services | 16.04% |
| 4 | Healthcare | 8.87% |
| 5 | Financials | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Kymera Therapeutics
KYMR
$8.59B
| $28.8M | 0.02% |
716,933
-80,748
| -10% | -$3.65M |
|
|
WAY
302
Waystar Holding Corp
WAY
$4.56B
| $28.7M | 0.02% |
781,708
-347,456
| -31% | -$10.7M |
|
|
BRDG
303
DELISTED
Bridge Investment Group
BRDG
| $28.6M | 0.02% |
3,402,475
+31,593
| +0.9% | +$311K |
|
304
Dyne Therapeutics
DYN
$4.85B
| $28.6M | 0.02% |
1,211,915
-135,037
| -10% | -$3.99M |
|
305
Expro Ltd
XPRO
$1.88B
| $28.5M | 0.02% |
2,282,518
-3,663
| -0.2% | -$51K |
|
|
WCC
306
WESCO International
WCC
$18.2B
| $28.4M | 0.02% |
+156,967
| New | +$29.7M |
|
307
AvalonBay Communities
AVB
$27B
| $28.2M | 0.02% |
128,325
+2,407
| +2% | +$543K |
|
308
Hershey
HSY
$36B
| $28M | 0.02% |
165,108
-3,712
| -2% | -$666K |
|
309
Rush Enterprises Class A
RUSHA
$6.43B
| $27.9M | 0.02% |
509,380
+475,384
| +1,398% | +$27.1M |
|
310
Varonis Systems
VRNS
$4.98B
| $27.7M | 0.02% |
623,481
-11,617
| -2% | -$604K |
|
|
UMH
311
UMH Properties
UMH
$1.3B
| $27.6M | 0.02% |
1,462,585
+145,310
| +11% | +$2.77M |
|
312
Regal Rexnord
RRX
$14.6B
| $27.3M | 0.02% |
175,702
+44,447
| +34% | +$7.51M |
|
313
Applied Materials
AMAT
$434B
| $27.1M | 0.02% |
166,922
+2,313
| +1% | +$419K |
|
314
Riskified
RSKD
$696M
| $27M | 0.02% |
5,701,408
+19,264
| +0.3% | +$89.3K |
|
315
Hudbay
HBM
$11B
| $26.8M | 0.02% |
3,306,276
+7,462
| +0.2% | +$66.9K |
|
316
Avantor
AVTR
$9.25B
| $26.2M | 0.02% |
1,244,461
-704,059
| -36% | -$15.8M |
|
317
Hubbell
HUBB
$26.5B
| $26.2M | 0.02% |
62,577
+43,671
| +231% | +$19.5M |
|
318
Similarweb
SMWB
$650M
| $26.1M | 0.02% |
+1,839,055
| New | +$20.3M |
|
319
Western Midstream Partners
WES
$19.3B
| $26M | 0.02% |
677,205
-1,069,042
| -61% | -$41.3M |
|
320
Samsara
IOT
$22.5B
| $25.9M | 0.02% |
593,562
+589,174
| +13,427% | +$29M |
|
321
Procore
PCOR
$8.49B
| $25.9M | 0.02% |
345,881
+86,277
| +33% | +$6.12M |
|
322
CoStar Group
CSGP
$12.1B
| $25.3M | 0.02% |
353,938
-101,384
| -22% | -$7.66M |
|
323
Plains GP Holdings
PAGP
$5.04B
| $25.3M | 0.02% |
1,378,478
-1,336,063
| -49% | -$24.8M |
|
324
IDEAYA Biosciences
IDYA
$3.48B
| $25M | 0.02% |
974,636
+2,370
| +0.2% | +$67.1K |
|
325
NeoGenomics
NEO
$2.09B
| $25M | 0.02% |
1,514,756
+238,288
| +19% | +$3.7M |
|
Similar funds
Jennison Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Jennison Associates held 642 positions worth $165B, up 2.2% from $161B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jennison Associates withdrew a net $6.01B in Q4 2024, closing 70 positions and reducing 253 holdings. Its most notable exit was Centene, an estimated $129M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Jennison Associates opened a new position in Spotify worth $1.34B.
- Jennison Associates's largest Q4 2024 buy was Spotify: 2,985,326 shares worth $1.34B.
- Jennison Associates added most to Walmart Inc in Q4 2024, an estimated $595M increase.
- Jennison Associates's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $1.78B.
- Jennison Associates fully exited Centene in Q4 2024, selling an estimated $129M.
- Jennison Associates's ten largest holdings make up 47% of its $165B portfolio in Q4 2024.
- Jennison Associates opened 84 new positions and closed 70 in Q4 2024.
- Jennison Associates's portfolio value rose 2.2% quarter-over-quarter to $165B.
Based on Jennison Associates's 13F filing for Q4 2024, filed 24 Jan 2025.